XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
$1.62+0.08 (+5.19%)
Close on Nov 17, 2026Market cap $15.33MP/E –Yield –
XTL Biopharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
No price to book ratio figures for XTL Biopharmaceuticals
XTL Biopharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?